Evidence map›Paper›PMID 30627554›Full record

ArticleBioMed research international2018

Effect of Neoadjuvant Hormone Therapy on Resection Margin and Survival Prognoses in Locally Advanced Prostate Cancer after Prostatectomy Using Propensity-Score Matching.

Sung Han Kim, Eun Young Park, Jungnam Joo, Jae Young Joung, Ho Kyung Seo, Jinsoo Chung, Kang Hyun Lee

Abstract read
In one paragraph

Article in BioMed research international, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Sung Han KimDepartment of Urology, Center for Prostate Cancer, Research Institute and Hospital of National Cancer Center, Goyang, Republic of Korea.ORCID 0000-0002-1689-5203
Eun Young ParkBiometrics Research Branch, Division of Cancer Epidemiology and Prevention, Research Institute and Hospital of National Cancer Center, Goyang, Republic of Korea.
Jungnam JooBiometrics Research Branch, Division of Cancer Epidemiology and Prevention, Research Institute and Hospital of National Cancer Center, Goyang, Republic of Korea.ORCID 0000-0001-6961-8122
Jae Young JoungDepartment of Urology, Center for Prostate Cancer, Research Institute and Hospital of National Cancer Center, Goyang, Republic of Korea.ORCID 0000-0002-7971-211X
Ho Kyung SeoDepartment of Urology, Center for Prostate Cancer, Research Institute and Hospital of National Cancer Center, Goyang, Republic of Korea.ORCID 0000-0003-2601-1093
Jinsoo ChungDepartment of Urology, Center for Prostate Cancer, Research Institute and Hospital of National Cancer Center, Goyang, Republic of Korea.ORCID 0000-0003-2251-5331
Kang Hyun LeeDepartment of Urology, Center for Prostate Cancer, Research Institute and Hospital of National Cancer Center, Goyang, Republic of Korea.ORCID 0000-0003-0041-2243

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study aimed to investigate the effect of neoadjuvant hormone therapy (NHT) on resection margin positivity, biochemical-recurrence- (BCR-) free survival, and overall survival (OS) in 176 patients with locally advanced prostate cancer (LAPC) treated with radical prostatectomy using propensity-score matching, including 79 (44.9%) patients treated with the NHT. Fifty pairs of one-to-one propensity-score matching were matched to investigate the pure effect of NHT on resection margin positivity, BCR, and OS with a statistical significance of

Indexed as

AgedAntineoplastic Agents, HormonalHumansMaleMargins of ExcisionNeoadjuvant TherapyPrognosisPropensity ScoreProstateProstatectomyProstate-Specific AntigenProstatic NeoplasmsSurvival AnalysisAntineoplastic Agents, HormonalProstate-Specific Antigen

Identifiers

PMID30627554
PMCPMC6304638

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.